Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Frontiers in Pharmacology|May 31, 2019
Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in ChinaXingyun Hou, Xu Wan, Bin WuJournal of Diabetes Research|May 1, 2020
The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited SettingJing Ma, Xu Wan, Bin WuJournal of Diabetes|October 5, 2017
Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited settingBin Wu, Xu Wan, Jing MaGenetic Testing and Molecular Biomarkers|December 2, 2015
Association of the Polymorphism in Nucleobindin 2 Gene and the Risk of Metabolic SyndromeRui Wang, Jing Wang, Xu WanClinical Therapeutics|February 5, 2019
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 DiabetesHuafeng Cheng, Xu Wan, Jing Ma, et al.Advances in Therapy|November 4, 2018
Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 DiabetesTe Li, Xu Wan, Jin Ma, et al.Annals of Translational Medicine|March 12, 2021
The risk of venous thromboembolism in cancer patients receiving chemotherapy: a meta-analysis with systematic reviewYun Bao, Xu Wan, Jie Fu, et al.Cost Effectiveness and Resource Allocation : C/E|March 7, 2020
Economic evaluation of dapagliflozin versus metformin in Chinese patients whose diabetes is inadequately controlled with diet and exerciseHua Nian, Xu Wan, Jing Ma, et al.Colloids and Surfaces. B, Biointerfaces|November 6, 2015
Incorporation of lapatinib into human serum albumin nanoparticles with enhanced anti-tumor effects in HER2-positive breast cancerXu Wan, Xiaoyao Zheng, Xiaoying Pang, et al.Life Sciences|December 14, 2020
Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cellsChi Zhang, Wen Yuan, Ying Wu, et al.Pageof 5